FDA Orders Psychiatric Warn Labels On Asthma Drugs
The U.S. Food and Drug Administration has asked AstraZeneca Pharmaceuticals LP, Merck & Co. Inc. and Cornerstone Therapeutics Inc. to update the labeling for their leukotriene modifiers class of asthma drugs...To view the full article, register now.
Already a subscriber? Click here to view full article